The business address of the reporting entities is 300 Carlsbad Village Drive, Suite 108A-228, Carlsbad, CA 92008.

Mr. Ferayorni's principal occupation or employment is the managing member of a holding company located at the address listed above. He is the sole owner of Tamarack GP, the general partner of Tamarack LP, of which he also the sole limited partner. He is also the sole owner of Tamarack PFGP, the general partner of Tamarack GHF.

Neither Mr. Ferayorni , nor any of the other reporting entities, has, during the last five years, such person has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors.)

Neither Mr. Ferayorni, nor any of the other reporting entities, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Mr. Ferayorni is a United States Citizen. Tamarack Capital GP, LLC, is a Delaware limited liability company Tamarack Advisers, LP, is a Delaware limited partnership Tamarack Capital Management, LLC, is a Delaware limited liability company Tamarack Global Healthcare Fund, L.P., is a Delaware limited partnership

Funds for the purchases of Common Stock were obtained from the working capital of the reporting entities, and grants of restricted stock from the issuer.

The purchases of Common Stock were made solely for investment purposes. Depending upon market conditions and other factors, the reporting entities may increase beneficial ownership of securities of the Issuer, or alternatively, may dispose of some or all of the securities of the Issuer that it beneficially owns.

Reference is made hereby to Items 7-11 and 13 of the Cover Page Reporting Person information of this Schedule, which Items are incorporated by reference herein. The calculation of percentage of beneficial ownership in the items 13 were derived from the Issuer's Form 10-Q filed with the Securities and Exchange Commission on December 14, 2023, in which The Issuer stated that the number of shares of Common Stock outstanding as of December 11, 2023 was 58,829,461, adjusted for the received warrants for Mr. Ferayorni in his information.

Reference is made hereby to Items 7-11 and 13 of the Cover Page Reporting Person information of this Schedule, which Items are incorporated by reference herein. The calculation of percentage of beneficial ownership in the items 13 were derived from the Issuer's Form 10-Q filed with the Securities and Exchange Commission on December 14, 2023, in which The Issuer stated that the number of shares of Common Stock outstanding as of December 11, 2023 was 58,829,461, adjusted for the received warrants for Mr. Ferayorni in his information.

The implied acquisition of the shares by Justin Ferayorni was through a grant by Streamline Health Solutions Inc. of warrants to obtain the listed number of shares Date #of shares Price ---------------- ---------------- $------------- 02/07/2024 448,718 0.00

Other than the reporting persons, the additional private fund for which Tamarack PFGP serves as general partner and Tamarack LP serves as investment manager, and the owners of the family accounts managed by Mr. Ferayorni, no person has the right to receive, or the power to direct the receipt of dividends from, or the proceeds from, the sale of, the common stock mentioned in item 1.

Not applicable.

None

None